Dr. Anna Maria Tolomeo

Curriculum Vitae

Scopus ID: 56764354400
Anna Maria Tolomeo is Junior Principal Investigator at the Pediatric Research Institute “Città della Speranza” and Principal Scientist and Lab Coordinator at the University of Padova. Graduated in Evolutionary Biology at the University of Padova (Italy) in 2014, Anna Maria earned the Ph.D. in Developmental Medicine at the same University of Padova in 2018. She is Scientific Coordinator of Unit on Food and Drug Administration (FDA)-certified Nanoparticles manufacturing for Typeone Biomaterials Srl (Lecce, Italy) and she was Co-Supervisor of Unit on Extracellular Vesicles (EVs) Quality Assurance for Bronchopneumodysplasia treatment, for Exo Biologics SA (Neil, Belgium). In July 2023 European Medicines Agency (EMA) authorized the ‘first in man’ study. Since 2023, she is Scientific Coordinator of two Research Units on Organ Reconditioning and 3D-bioprinted-scaffolds development, for Life4Hub (Living Innovative Fully Engineered for HUman Bioreplacement) national center, focused on patient-specific medicine. With a strong expertise in the study of EVs as therapeutic tools, in 2019, she collaborated on the patent: “Extracellular vesicles isolated from genetically modified cells over-expressing SerpinB3 for use in medicine”.